Results 271 to 280 of about 17,175,483 (375)

Navigating Diagnostic Ambiguities in Cardiac Amyloidosis: Insights from a Case with Delayed Diagnosis of AL Amyloidosis. [PDF]

Am J Case Rep
Al Hazzouri A, Daou RM, Attieh P, Ibrahim Z, Ghadieh HE, Harbieh B.   +5 more
europepmc   +1 more source

Technical considerations and review of urinary microRNAs as biomarkers for chronic kidney disease in dogs and cats

Veterinary Clinical Pathology, EarlyView.
Abstract MicroRNAs (miRNAs or miRs) are small, non‐coding RNAs that play a crucial role in gene regulation, making them potential biomarkers for various diseases. In the field of veterinary medicine, there is a growing interest in exploring the diagnostic and therapeutic potential of miRNAs in kidney diseases affecting dogs and cats.
Candice P. Chu, Mary B. Nabity
wiley   +1 more source

Heart transplantation in systemic (AL) amyloidosis: A retrospective study of eight French patients

, 2008
Aude Mignot, Shaïda Varnous, M Redonnet, Arnaud Jaccard, Éric Epailly, Emmanuelle Vermès, P. Boissonnat, I Gandjbakhch, D Herpin, Guy Touchard, Frank Bridoux   +10 more
openalex   +1 more source

From the Bone Marrow to the Heart: Cardiac Recovery in AL Amyloidosis. [PDF]

JACC Asia
Smiley DA, Einstein AJ.
europepmc   +1 more source

World Association for Veterinary Dermatology Consensus Statement for Diagnosis, and Evidence‐Based Clinical Practice Guidelines for Treatment and Prevention of Canine Leishmaniosis

Veterinary Dermatology, EarlyView.
Hyperkeratosis of (a) the footpads and (b) the nasal planum. ABSTRACT Background Canine leishmaniosis (CanL) due to Leishmania infantum remains common, and veterinarians do not always follow scientifically sound approaches for diagnosis, treatment and prevention. Objectives To provide consensus guidelines for diagnosis and evidence‐based guidelines for
Manolis N. Saridomichelakis, Gad Baneth, Silvia Colombo, Filipe Dantas‐Torres, Lluís Ferrer, Alessandra Fondati, Guadalupe Miró, Laura Ordeix, Domenico Otranto, Chiara Noli   +9 more
wiley   +1 more source

Therapeutic Outcome of Cyclic VAD (Vincristine, Doxorubicin and Dexamethasone) Therapy in Primary Systemic AL Amyloidosis Patients

, 2008
Ko‐ichi Tazawa, Masayuki Matsuda, Takuhiro Yoshida, Takahisa Gono, Nagaaki Katoh, Yasuhiro Shimojima, Wataru Ishii, Tomohisa Fushimi, Jun Koyama, Shu‐ichi Ikeda   +9 more
openalex   +2 more sources

Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis. [PDF]

Br J Haematol
Khwaja J, Ravichandran S, Cohen O, Foard D, Low M, Martinez-Naharro A, Venneri L, Fontana M, Hawkins PN, Gillmore J, Lachmann HJ, Whelan C, Mahmood S, Wechalekar A.   +13 more
europepmc   +1 more source

The causative role of amyloidosis in the cardiac complications of Alzheimer's disease: a comprehensive systematic review

The Journal of Physiology, EarlyView.
Abstract figure legend Schematic illustration of the bidirectional causative link between cerebral amyloid‐beta (Aβ) angiopathy and cardiovascular disease in Alzheimer's disease (AD). Common cardiovascular risk factors like microvascular thrombosis, diabetes, atrial fibrillation, hypertension and atherosclerosis lead to cerebral hypoperfusion and ...
Samuel Parker, Andrew F. James, Svetlana Mastitskaya   +2 more
wiley   +1 more source

Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy. [PDF]

QJM
Kashio T, Horino T, Yagyu K, Osakabe Y, Inotani S, Terada Y.   +5 more
europepmc   +1 more source

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.

Blood, 2017
Eli Muchtar, M. Gertz, Shaji K. Kumar, M. Lacy, D. Dingli, F. Buadi, M. Grogan, S. Hayman, P. Kapoor, N. Leung, A. Fonder, M. Hobbs, Y. Hwa, W. Gonsalves, R. Warsame, T. Kourelis, S. Russell, J. Lust, Yi Lin, R. Go, S. Zeldenrust, R. Kyle, S. Rajkumar, A. Dispenzieri   +23 more
semanticscholar   +1 more source